SCHEMBL5035679

SCHEMBL5035679

CC(C)(C)OC(=O)CN(CCN(CC(=O)OC(C)(C)C)CC(Cc1ccc([N+](=O)[O-])cc1)N(CC(=O)OC(C)(C)C)Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1D1 P20393 5/20 0.52
NR1H3 Q13133 1/20 0.43
ITGA4 P13612 1/20 0.41
ITGB7 P26010 1/20 0.41
MC4R P32245 1/20 0.40
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
CRHBP P24387 2/20 0.39
CRHR2 Q13324 2/20 0.39
ALDH1A1 P00352 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 2/20 0.37
NPC1 O15118 1/20 0.37
TP53 P04637 1/20 0.37
RAB9A P51151 1/20 0.37
TMEM97 Q5BJF2 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
MAPK1 P28482 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
MMP1 P03956 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15388283 0.89 NR1D1 (0.52) NR1D1NR1H3ITGA4ITGB7KMT2A
SCHEMBL5033940 0.87 NR1D1 (0.36) NR1D1NR1H3NPC1TP53RAB9A
SCHEMBL9924678 0.85 NR1D1 (0.48) NR1D1NR1H3ITGA4ITGB7KMT2A
SCHEMBL5032656 0.84 PPARG (0.41) MMP1MMP2MMP9MMP8MMP13
SCHEMBL7804379 0.83 NR1D1 (0.50) NR1D1NR1H3ITGA4ITGB7KMT2A
SCHEMBL8090953 0.82 ATM (0.39) NR1D1ITGA4ITGB7KMT2AMEN1
SCHEMBL13014185 0.78 NR1D1 (0.66) NR1D1NR1H3ALDH1A1SMN1; SMN2LMNA
SCHEMBL13014193 0.78 NR1D1 (0.66) NR1D1NR1H3CRHBPCRHR2ALDH1A1
SCHEMBL15388528 0.77 NR1D1 (0.48) NR1D1NR1H3MMP1MMP2MMP9
SCHEMBL17714014 0.77 ITGA4 (0.56) NR1D1NR1H3ITGA4ITGB7KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080176339-A1 NEUTRAL LABELING REACTANTS AND CONJUGATES DERIVED THEREOF WALLAC OY (FI) 2008-07-24 US disclosed
US-20080176339-A1 NEUTRAL LABELING REACTANTS AND CONJUGATES DERIVED THEREOF WALLAC OY (FI) 2008-07-24 US disclosed
WO-2007082996-A1 NEUTRAL LABELING REACTANTS AND CONJUGATES DERIVED THEREOF WALLAC OY (FI) 2007-07-26 WO disclosed
US-20070166228-A1 Neutral labeling reactants and conjugates derived thereof WALLAC OY (FI) 2007-07-19 US disclosed
US-20070166228-A1 Neutral labeling reactants and conjugates derived thereof WALLAC OY (FI) 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070166228-A1 Neutral labeling reactants and conjugates derived thereof NAAA, DNPEP, PAM NR1D1 4118/4885NR1H3 4182/4885ITGA4 2587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.